Osterweis Capital Management Inc Viking Therapeutics, Inc. Transaction History
Osterweis Capital Management Inc
- $2.15 Billion
- Q4 2024
A detailed history of Osterweis Capital Management Inc transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Osterweis Capital Management Inc holds 155,445 shares of VKTX stock, worth $4.5 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
155,445
Previous 125,520
23.84%
Holding current value
$4.5 Million
Previous $7.95 Million
21.28%
% of portfolio
0.29%
Previous 0.47%
Shares
4 transactions
Others Institutions Holding VKTX
# of Institutions
468Shares Held
65.8MCall Options Held
5.84MPut Options Held
3.76M-
Vanguard Group Inc Valley Forge, PA10.2MShares$294 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$174 Million0.01% of portfolio
-
State Street Corp Boston, MA4.93MShares$143 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.59MShares$75.1 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.16MShares$62.5 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.22B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...